-
Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine
- Size:
3 kB
- Last Update:
12.11.2012
-
Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine
- Size:
6 kB
- Last Update:
12.11.2012
-
Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine
- Size:
2 MB
- Last Update:
12.11.2012
-
Boehringer Ingelheim und die ETH Zürich verkünden Forschungskooperation im Bereich Diabetes und Fettleibigkeit
- Size:
9 kB
- Last Update:
5.11.2012
-
Prof. Dr Dr Andreas Barner,Boehringer Ingelheim GmbH, Corporate Board Divisions Human Resources, Research & Development and Medicine
- Size:
19 kB
- Last Update:
12.11.2012
-
Dr Wolfram Carius, Boehringer Ingelheim GmbH, Corporate Board Divisions Biopharmaceuticals and Operations
- Size:
21 kB
- Last Update:
12.11.2012
-
Engelbert Tjeenk Willink, Boehringer Ingelheim GmbH, Corporate Board Division Pharma Marketing and Sales
- Size:
22 kB
- Last Update:
12.11.2012
-
- Size:
307 kB
- Last Update:
14.11.2012
-
- Size:
5 kB
- Last Update:
14.11.2012
-
Macha S, Rose P, Mattheus M, Cinca R, Pinnetti S, Broedl UC, Woerle HJ Phase I (1245.13; encore of ADA 2012)
- Size:
213 kB
- Last Update:
6.11.2012